Advanced Enzyme Technologies Ltd

NSE: ADVENZYMES · BSE: 540025 · Pharmaceuticals & Biotechnology · 62 announcements

Share price: ₹272.05
Market cap: ₹3,046 Cr
Revenue (annual): ₹745.8 Cr
Net profit (annual): ₹168.7 Cr
P/E (TTM): 18.4×Sector 47.4×
Promoter holding: 43.24%-0.02% QoQ
FII holding: 26.70%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Capital Structure Change 28 Promoter Reclassification 2 Other Announcement 2 Merger & Restructuring 2 Earnings Call 2 Annual General Meeting 2 Results Update 1 Financial Results 1 Business Update 1 Board Meeting Outcome 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

27 Aug 2026 18:31 IST BSE

Other Announcement

Advanced Enzyme Technologies Other Announcement

Advanced Enzyme Technologies Ltd bought back 68,248 equity shares on August 27, 2026, at an average price of ₹298.11, totaling approximately ₹2.03 Crore.

Value: ₹2.03 Cr

Read the filing ↗

18 Jul 2026 17:05 IST BSE

Other Announcement

Advanced Enzyme Technologies Other Announcement

Advanced Enzyme Technologies filed its quarterly shareholding pattern for the period ended June 30, 2026, in compliance with SEBI regulations.

Read the filing ↗